Skip to main navigation Skip to search Skip to main content

Candidemia and antifungal susceptibility in Peruvian hospitals

  • Romina Rios-Blanco
  • , Marcello Olsen-Verme
  • , Fiorella Palomino
  • , Michelle Regal Ludowieg
  • , Jan Jacobs
  • , Fiorella Krapp
  • , Beatriz Bustamante
  • , Coralith Garcia
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
  • Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado
  • Institute of Tropical Medicine
  • KU Leuven

Research output: Contribution to journalArticlepeer-review

Abstract

Worldwide, Candida bloodstream infections have presented an increase in non-albicans Candida species and resistance to antifungal agents. Objective: To describe the microbiological characteristics of consecutive Candida blood culture isolates. Methods: This study analyzed 73 consecutive Candida blood isolates recovered between July 2017 and July 2019 from routine patient care at 15 Peruvian hospitals, assessing susceptibility to four antifungal agents. Results: The species most frequently detected were Candida parapsilosis 39 (53.4%), Candida albicans 23 (31.5%), and Candida tropicalis 5 (6.8%). Conclusions: All isolates were susceptible to amphotericin B, fluconazole, voriconazole, and anidulafungin. There is a predominance of non-albicans Candida cases in Peru and a high susceptibility to current antifungal drugs.

Translated title of the contributionCandidemia y susceptibilidad a antifúngicos en hospitales peruanos
Original languageEnglish
Pages (from-to)130-135
Number of pages6
JournalRevista Medica Herediana
Volume36
Issue number2
DOIs
StatePublished - Apr 2025

Keywords

  • Antifungal Drug Resistance
  • Antifungal agents
  • Candida
  • Candidemia

Fingerprint

Dive into the research topics of 'Candidemia and antifungal susceptibility in Peruvian hospitals'. Together they form a unique fingerprint.

Cite this